Related Experiment Videos
The PTEN, Mdm2, p53 tumor suppressor-oncoprotein network
Lindsey D Mayo1, David B Donner
1Dept of Microbiology and Immunology, Walther Oncology Center, Indiana University School of Medicine, Indianapolis, IN 46202, USA. ldmayo@iupui.edu
Abstract:
Oncoproteins and tumor-suppressor proteins regulate cell growth and viability. Recent observations show that phosphoinositide 3-kinase (PtdIns 3-kinase)-Akt signaling promotes the phosphorylation and movement of the Mdm2 oncoprotein into the nucleus, where it downregulates the p53 tumor-suppressor protein. The PTEN tumor suppressor protein inhibits activation of Akt and this restricts Mdm2 to the cytoplasm. Restriction of Mdm2 to the cytoplasm promotes p53 function and thereby sustains the sensitivity of cancer cells to chemotherapy. p53 acutely induces Mdm2, providing damaged cells the opportunity for repair, but subsequently induces PTEN, favoring the death of mutated or irrevocably damaged cells. Thus, oncoproteins and tumor suppressor proteins are networked to promote normal cell function and eliminate mutated cells.
Insights
Oncoproteins and tumor suppressor proteins regulate cell growth. The phosphoinositide 3-kinase (PtdIns 3-kinase)-Akt pathway influences Mdm2 and p53 interactions, impacting cancer cell chemotherapy sensitivity.
Area of Science:
- Molecular Biology
- Cell Biology
- Oncology
Background:
- Oncoproteins and tumor suppressor proteins are key regulators of cell growth and viability.
- The phosphoinositide 3-kinase (PtdIns 3-kinase)-Akt signaling pathway plays a critical role in cellular regulation.
- Dysregulation of these proteins is implicated in cancer development and progression.
Purpose of the Study:
- To elucidate the regulatory network between oncoproteins and tumor suppressor proteins in cell growth and viability.
- To investigate the role of the PtdIns 3-kinase-Akt pathway in the nuclear localization of Mdm2 and its effect on p53.
- To understand how PTEN tumor suppressor protein influences Akt activation and Mdm2 localization, impacting cancer cell chemotherapy sensitivity.
Main Methods:
- Analysis of protein-protein interactions and subcellular localization.
- Investigation of signaling pathway activation and inhibition.
- Assessment of cancer cell response to chemotherapy.
Main Results:
- PtdIns 3-kinase-Akt signaling promotes Mdm2 oncoprotein nuclear translocation, leading to p53 tumor suppressor downregulation.
- PTEN inhibits Akt activation, restricting Mdm2 to the cytoplasm and enhancing p53 function.
- Cytoplasmic restriction of Mdm2 sustains cancer cell sensitivity to chemotherapy.
Conclusions:
- Oncoproteins and tumor suppressor proteins are intricately networked to maintain normal cell function.
- The interplay between PtdIns 3-kinase-Akt, Mdm2, PTEN, and p53 is crucial for eliminating mutated or damaged cells.
- Targeting this network may offer strategies to enhance cancer chemotherapy efficacy.